TRECARICHI, ENRICO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 4.906
AS - Asia 2.882
EU - Europa 1.470
SA - Sud America 916
Continente sconosciuto - Info sul continente non disponibili 211
AF - Africa 78
OC - Oceania 3
Totale 10.466
Nazione #
US - Stati Uniti d'America 4.713
SG - Singapore 1.175
IT - Italia 772
BR - Brasile 692
CN - Cina 581
VN - Vietnam 449
IN - India 250
DE - Germania 159
GB - Regno Unito 130
HK - Hong Kong 109
CA - Canada 104
BD - Bangladesh 94
AR - Argentina 82
NL - Olanda 81
SE - Svezia 77
FI - Finlandia 67
MX - Messico 51
ID - Indonesia 38
EC - Ecuador 34
CO - Colombia 28
IQ - Iraq 27
ZA - Sudafrica 25
FR - Francia 24
CZ - Repubblica Ceca 22
PY - Paraguay 22
VE - Venezuela 21
TR - Turchia 20
ES - Italia 19
RU - Federazione Russa 19
UA - Ucraina 19
CL - Cile 18
PL - Polonia 18
JP - Giappone 17
UZ - Uzbekistan 16
PK - Pakistan 14
AE - Emirati Arabi Uniti 13
PE - Perù 12
SA - Arabia Saudita 12
CR - Costa Rica 11
SC - Seychelles 11
AT - Austria 10
TN - Tunisia 10
KE - Kenya 8
KZ - Kazakistan 8
LT - Lituania 8
IL - Israele 7
EG - Egitto 6
ET - Etiopia 6
IE - Irlanda 6
JO - Giordania 6
AL - Albania 5
CH - Svizzera 5
MA - Marocco 5
PH - Filippine 5
RO - Romania 5
AZ - Azerbaigian 4
BG - Bulgaria 4
HN - Honduras 4
JM - Giamaica 4
TH - Thailandia 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
DZ - Algeria 3
EE - Estonia 3
EU - Europa 3
HR - Croazia 3
IR - Iran 3
KG - Kirghizistan 3
LB - Libano 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
BS - Bahamas 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KI - Kiribati 2
KR - Corea 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
GR - Grecia 1
HT - Haiti 1
Totale 10.252
Città #
San Jose 925
Dallas 634
Ashburn 466
Singapore 439
Chandler 270
Santa Clara 240
Council Bluffs 190
Bengaluru 189
Hefei 189
Ho Chi Minh City 169
Milan 130
Munich 121
Beijing 110
Princeton 108
Lawrence 104
Hanoi 101
Chicago 98
Hong Kong 94
London 82
Wilmington 74
Los Angeles 61
São Paulo 61
Phoenix 59
Rome 59
Turku 48
New York 47
Ottawa 41
Des Moines 30
Palermo 28
San Francisco 28
Boardman 25
The Dalles 25
Da Nang 24
Brooklyn 22
Olomouc 22
Montreal 21
Buffalo 20
Chennai 20
Atlanta 19
Catanzaro 19
San Nicola Manfredi 19
Helsinki 18
Amsterdam 16
Warsaw 16
Guayaquil 15
Naples 15
Rio de Janeiro 15
Tokyo 15
Bari 14
Brasília 14
Tashkent 14
Cosenza 13
Denver 13
Haiphong 13
Porto Alegre 13
Thái Bình 13
Baghdad 12
Biên Hòa 12
Boston 12
Curitiba 12
Hải Dương 12
Orem 12
Jakarta 11
Manchester 11
Toronto 11
Campinas 10
Mexico City 10
Salvador 10
Belo Horizonte 9
Caracas 9
Florence 9
Rende 9
Buenos Aires 8
Columbus 8
Johannesburg 8
Nairobi 8
Padova 8
Shanghai 8
Taranto 8
Asunción 7
Dhaka 7
Guarulhos 7
Manaus 7
Miami 7
Ninh Bình 7
Pune 7
Santiago 7
Seattle 7
Settingiano 7
Stockholm 7
Sumaré 7
Turin 7
Assago 6
Bogotá 6
Bologna 6
Catania 6
Durban 6
Maryland Heights 6
Medellín 6
Mumbai 6
Totale 6.014
Nome #
(1,3)-beta-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 481
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 119
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 103
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 101
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 98
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 92
When Viruses Meet Fungi: Tackling the Enemies in Hematology 86
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 85
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 84
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia 84
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 84
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 83
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 82
Azole resistance of Candida glabrata in a case of recurrent fungemia 82
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 82
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 80
Use of colistin in adult patients: a cross-sectional study 80
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium 79
Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy 78
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 78
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 76
SARS-CoV-2: Some Aspects of Molecular Evolution, Cellular Pathogenesis, and Immune System Mechanism Elusion 75
Evolving phenotypes of non-hospitalized patients that indicate long COVID 74
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 73
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 71
The role of Gram-negative bacteria in skin and soft tissue infections 70
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 70
Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study 70
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 69
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 69
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 69
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 68
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 67
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 67
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 67
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 66
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 66
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 65
In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry 65
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 64
Safety and Effectiveness of Transvenous Lead Extraction in Octogenarians 64
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 64
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 64
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 63
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 63
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality 62
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence 62
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 62
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 62
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 62
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 61
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 61
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 61
Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV 61
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 60
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 60
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 58
Identifying Patients Harboring Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System 58
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 58
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 58
Predictivity of frontal QRS-T angle for death in COVID-19 patients may differ by age 58
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 57
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 57
Outcome of hbv screening and vaccination in a migrant population in southern italy 57
Are we doing enough for controlling tuberculosis and multi-drug resistance in an epicenter of the current migration emergency (Calabria Region, Southern Italy)? 57
Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible Gram-negative bacteria 57
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 57
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 57
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study 56
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 56
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience 55
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients 55
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 55
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-beta-Lactamase Production and Inadequate Initial Antibiotic Therapy 55
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4 55
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 55
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure. 55
Lights and Shadows of Long COVID: Are Latent Infections the Real Hidden Enemy? 55
Incipient tuberculosis: a comprehensive overview 54
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 54
Lights and Shadows of Sepsis Management: Challenges and Future Perspectives 54
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 54
Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic 54
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 54
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 54
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone 54
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care? 53
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications 53
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 52
INTERLEUKIN-62/LYMPHOCYTE AS A PROPOSED PREDICTIVE INDEX FOR COVID-19 PATIENTS TREATED WITH MONOCLONAL ANTIBODIES 52
Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study 52
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections 52
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae: Importance of inadequate initial antimicrobial treatment 52
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 52
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality 51
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 51
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 50
Prosthetic valve endocarditis: predictors of early outcome of surgical therapy. A multicentric study 50
BOTULISMO 50
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy 50
Totale 6.907
Categoria #
all - tutte 83.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022312 0 0 0 64 8 3 31 78 22 43 62 1
2022/2023855 218 60 24 74 76 64 13 54 141 48 76 7
2023/2024522 89 77 20 35 36 112 34 16 3 18 41 41
2024/20252.024 211 63 51 145 197 241 76 80 177 122 263 398
2025/20265.422 262 655 909 969 441 196 533 285 530 385 158 99
2026/20271.128 51 240 631 206 0 0 0 0 0 0 0 0
Totale 10.466